✦ LIBER ✦

Trastuzumab Emtansine: A Review of Its Use in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab-Based Therapy

✍ Scribed by Dhillon, Sohita

Book ID: 125386850
Publisher: Springer International Publishing AG
Year: 2014
Tongue: English
Weight: 402 KB
Volume: 74
Category: Article
ISSN: 0012-6667
DOI: 10.1007/s40265-014-0201-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trastuzumab-based neoadjuvant therapy in

Trastuzumab-based neoadjuvant therapy in patients with HER2-positive breast cancer

✍ Helena R. Chang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 348 KB 👁 2 views

Trastuzumab: A Review of Its Use in HER2

Trastuzumab: A Review of Its Use in HER2-Positive Advanced Gastric Cancer

✍ Sanford, Mark 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 486 KB

Subcutaneous trastuzumab: a review of it

Subcutaneous trastuzumab: a review of its use in HER2-positive breast cancer

✍ Sanford, Mark 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 477 KB

FDA Approval: Ado-Trastuzumab Emtansine

FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer

✍ Amiri-Kordestani, L.; Blumenthal, G. M.; Xu, Q. C.; Zhang, L.; Tang, S. W.; Ha, 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 262 KB

Prognostic value of phosphorylated HER2

Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab

✍ Kurebayashi, Junichi; Kanomata, Naoki; Yamashita, Tetsumasa; Shimo, Toshiro; Miz 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 412 KB

Outcome impact of PIK3CA mutations in HE

Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab

✍ Cizkova, M; Dujaric, M-E; Lehmann-Che, J; Scott, V; Tembo, O; Asselain, B; Pierg 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 247 KB